During the past decade, Paracelsus Klinik Osnabrück conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paracelsus Klinik Osnabrück" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 1 trials sponsored, "III. Medizinische Klinik Mannheim" with 1 trials sponsored, "MEDA Pharma GmbH & Co. KG" with 1 trials sponsored and "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paracelsus Klinik Osnabrück" #1 collaborator was "Clinipace Worldwide" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Merck Healthcare Germany GmbH, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Trium Analysis Online GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Paracelsus Klinik Osnabrück" are "Lymphoma" (2 trials), "Brain and Central Nervous System Tumors" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Paracelsus Klinik Osnabrück" in a lesser frequency.

Most popular intervention types in "Paracelsus Klinik Osnabrück" are "Drug" (5 trials), "Radiation" (4 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (2 trials), "etoposide" (2 trials) and "filgrastim" (2 trials). Other intervention names were less common.

The vast majority of trials in "Paracelsus Klinik Osnabrück" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Paracelsus Klinik Osnabrück". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Paracelsus Klinik Osnabrück, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Paracelsus Klinik Osnabrück, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".